Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Welcome to the Divis Labs Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock.

Divis Laboratories Ltd is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The stock jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the ...

Vinay Rajani of HDFC Securities says Divis Labs share price has broken out from the box pattern on the daily chart with the ...

Divis Laboratories is reporting earnings from the most recent quarter on August 8. Wall Street analysts predict earnings per share of INR 11.98. Follow Divis Laboratories stock price in real-time here ...

Citi said it believes Divi's Laboratories' revenue and earnings before interest, tax, depreciation, and amortisation (EBITDA) ...

Earnings call Divi's Laboratories reported a 17% YoY revenue growth in Q2 FY26, driven by a record 56% contribution from custom synthesis. Margins remained resilient despite ongoing generic pricing ...

The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed its bullishness ...

Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25. Q2 growth was largely led by ...

Divi’s Laboratories (DIVI) Q2FY26 EBITDA was a beat; 7% above our estimates led by higher CS revenues. We expect margins to improve, led by better product mix and stable raw material prices. Mgmt.

Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for ...

On June 6, Divis Laboratories releases figures for Q4. Wall Street analysts expect Divis Laboratories will be reporting earnings per share of INR 14.95. Follow Divis Laboratories stock price in ...